Entering text into the input field will update the search result below

Roche's tocilizumab recommended for severe COVID by EMA advisory panel

Dec. 06, 2021 1:17 PM ETRoche Holding AG (RHHBY)By: Jonathan Block, SA News Editor

Roche Tower in Basel, Switzerland

olli0815/iStock Editorial via Getty Images

  • The European Medicine Agency's Committee for Medicinal Products for Human Use has recommended extending the approval of Roche's (OTCQX:RHHBY +0.6%) RoActemra (tocilizumab) for COVID-19 patients on corticosteroids and supplemental oxygen or mechanical ventilation.
  • The monoclonal

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.